Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-25-040247
Filing Date
2025-03-17
Accepted
2025-03-17 16:10:09
Documents
11
Period of Report
2025-03-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A gern-20250310.htm   iXBRL 8-K/A 49253
  Complete submission text file 0000950170-25-040247.txt   171768

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT gern-20250310.xsd EX-101.SCH 28871
13 EXTRACTED XBRL INSTANCE DOCUMENT gern-20250310_htm.xml XML 5235
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-20859 | Film No.: 25744498
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)